Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?
Articolo
Data di Pubblicazione:
2022
Abstract:
To date limited information about cefiderocol use is provided by real life studies. Our aim is to evaluate characteristics and outcome of patients with Gram-negative infections with limited therapeutic options treated with cefiderocol in combination or monotherapy.
Tipologia CRIS:
03A-Articolo su Rivista
Keywords:
Acinetobacter baumannii; Cefiderocol; Combination therapy; Gram negative bacteria; VAP
Elenco autori:
Corcione, Silvia; De Benedetto, Ilaria; Pinna, Simone Mornese; Vita, Davide; Lupia, Tommaso; Montrucchio, Giorgia; Brazzi, Luca; De Rosa, Francesco Giuseppe
Link alla scheda completa:
Pubblicato in: